Cargando…

1375. Laboratory Abnormalities Among Patients with Pulmonary Mycobacterium avium Complex Infections

BACKGROUND: Limited data are available regarding laboratory abnormalities in patients with pulmonary Mycobacterium avium complex (MAC) disease. METHODS: We included patients without cystic fibrosis who had pulmonary MAC and met ATS/IDSA disease criteria from the Northwest NTM Biobank with a complete...

Descripción completa

Detalles Bibliográficos
Autores principales:	Varley, Cara D, Henkle, Emily, Strnad, Luke, Ku, Jennifer, Brunton, Amanda, Winthrop, Kevin L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808944/ http://dx.doi.org/10.1093/ofid/ofz360.1239

Ejemplares similares

1899. Core Outcome Domains for Mycobacterium avium complex Pulmonary Disease Clinical Trials: Mycobacterium avium complex Core Outcomes Research (MACCOR)
por: Varley, Cara D, et al.
Publicado: (2023)

Use of Anti-Glycopeptidolipid-Core Antibodies Serology for Diagnosis and Monitoring of Mycobacterium avium Complex Pulmonary Disease in the United States
por: Hernandez, A G, et al.
Publicado: (2022)

192. Tolerability Outcomes of Multi-drug Antibiotic Treatment for Pulmonary Nontuberculous Mycobacterial Disease due to Mycobacterium avium Complex in U.S. Medicare Beneficiaries with Bronchiectasis
por: Ku, Jennifer, et al.
Publicado: (2021)

Disseminated Nontuberculous Mycobacteria in HIV-Infected Patients, Oregon, USA, 2007–2012
por: Varley, Cara D., et al.
Publicado: (2017)

Mycobacterium avium Complex: Addressing Gaps in Diagnosis and Management
por: Daley, Charles L, et al.
Publicado: (2020)

Treatment of Mycobacterium avium Complex Pulmonary Disease
por: Kwon, Yong-Soo, et al.
Publicado: (2019)

Prescribing Patterns for Treatment of Mycobacterium avium Complex and M. xenopi Pulmonary Disease in Ontario, Canada, 2001–2013
por: Brode, Sarah K., et al.
Publicado: (2019)

Validity of Diagnosis Code–Based Claims to Identify Pulmonary NTM Disease in Bronchiectasis Patients
por: Ku, Jennifer H., et al.
Publicado: (2021)

Management of Drug Toxicity in Mycobacterium avium Complex Pulmonary Disease: An Expert Panel Survey
por: van Ingen, Jakko, et al.
Publicado: (2020)

1365. Self-Reported Impacts of COVID-19 Pandemic on Patients with Bronchiectasis and Nontuberculous Mycobacterium Pulmonary Infections: Healthcare Avoidance and Other Impacts Across Delta and Omicron Waves
por: Miller, Haley, et al.
Publicado: (2023)

A marmoset model for Mycobacterium avium complex pulmonary disease
por: Peters, Jay, et al.
Publicado: (2023)

Pulmonary Mycobacterium avium Complex Infection Showing Extensive Consolidation
por: Yamazoe, Masami, et al.
Publicado: (2022)

Consolidations in Nodular Bronchiectatic Mycobacterium Avium Complex Lung Disease: Mycobacterium Avium Complex or Other Infection?
por: Im, Soo Ah, et al.
Publicado: (2010)

Role of ethambutol and rifampicin in the treatment of Mycobacterium avium complex pulmonary disease
por: Kim, Hyung-Jun, et al.
Publicado: (2019)

Serum oxidative stress in patients with pulmonary Mycobacterium avium complex disease
por: Wakabayashi, Hiroki, et al.
Publicado: (2019)

Exacerbating factors in elderly patients with Mycobacterium avium complex pulmonary disease
por: Kodaka, Norio, et al.
Publicado: (2021)

Myosteatosis as a prognostic factor of Mycobacterium avium complex pulmonary disease
por: Chung, Eunki, et al.
Publicado: (2023)

Longitudinal changes in radiographic features of pulmonary Mycobacterium avium complex diseases
por: Watanabe, Chie, et al.
Publicado: (2023)

COVID-19 pandemic management and the rheumatology patient
por: Varley, Cara D., et al.
Publicado: (2021)

A new 1.375-approximation algorithm for sorting by transpositions
por: Silva, Luiz Augusto G., et al.
Publicado: (2022)

1375. Strengthening Global Capacity to Detect Antimicrobial Resistance Threats
por: Benoit, Tina, et al.
Publicado: (2023)

Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments
por: Kumar, Kartik, et al.
Publicado: (2022)

Proposed Definitions for Epidemiologic and Clinical Studies of Mycobacterium avium Complex Pulmonary Disease
por: Plotinsky, Rachel N., et al.
Publicado: (2013)

Long-Term Treatment Outcome of Progressive Mycobacterium avium Complex Pulmonary Disease
por: Fukushima, Kiyoharu, et al.
Publicado: (2020)

Treatment outcomes of Mycobacterium avium complex pulmonary disease according to disease severity
por: Kim, Bo-Guen, et al.
Publicado: (2022)

Efficacy of three sputum specimens for the diagnosis of Mycobacterium avium complex pulmonary disease
por: Urabe, Naohisa, et al.
Publicado: (2023)

Treatment outcomes and relapse in patients with Mycobacterium avium-intracellulare complex pulmonary disease
por: Chang, Chia-Ling, et al.
Publicado: (2023)

Disseminated Mycobacterium avium Complex Infection in a Patient Treated With Immunosuppressants
por: Ito, Yuki, et al.
Publicado: (2023)

Thioridazine as Chemotherapy for Mycobacterium avium Complex Diseases
por: Deshpande, Devyani, et al.
Publicado: (2016)

Mycobacterium avium complex: An unusual cause of hypercalcemia
por: Chatterjee, Tulika, et al.
Publicado: (2021)

Role of Clofazimine in Treatment of Mycobacterium avium Complex
por: Nasiri, Mohammad Javad, et al.
Publicado: (2021)

Diagnosis and Management of Pulmonary NTM with a Focus on Mycobacterium avium Complex and Mycobacterium abscessus: Challenges and Prospects
por: Hendrix, Christian, et al.
Publicado: (2022)

Hospital-based antibiotic use in patients with Mycobacterium avium complex
por: Ricotta, Emily E., et al.
Publicado: (2018)

Radiological findings in nontuberculous mycobacterial pulmonary diseases: A comparison between the Mycobacterium avium complex and the Mycobacterium abscessus complex
por: Nagano, Hiroaki, et al.
Publicado: (2022)

Multiple opportunistic infections (pulmonary tuberculosis, Mycobacterium avium complex and parvovirus B19) in a single patient
por: John, Midhun T., et al.
Publicado: (2022)

A tale of two images: From mycobacterium avium complex-lung disease (MAC-LD) to mycobacterium avium complex-pleural disease()
por: Varkey, Mary Rithu, et al.
Publicado: (2021)

Treatment Outcome of Combination Therapy Including Clarithromycin for Mycobacterium avium Complex Pulmonary Disease
por: Kim, Eun Young, et al.
Publicado: (2011)

Prevalence and risk factors for chronic co-infection in pulmonary Mycobacterium avium complex disease
por: Fujita, Kohei, et al.
Publicado: (2014)

Retrospective investigation of combination therapy with clarithromycin and levofloxacin for pulmonary Mycobacterium avium complex disease
por: Shimomura, Hitoshi, et al.
Publicado: (2015)

Rapid pulmonary cavity formation caused by Mycobacterium avium complex in a chemotherapy patient
por: Nakamura, Ryo, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_uvonok5kvv4l0qsva9ncs6jnng